Our programs
Deep expertise in medicinal chemistry combined with our AI-powered discovery and translational platform accelerates the creation of our novel precision psychiatric therapies.
NMDAR Antagonist
Orally bioavailable
Rapid-acting
Fewer dissociative effects
Depression and other indications
New Chemical Entity
5-HT2AR Agonists
Hallucinogenic and non-halluncingenic
Optimized duration of effect
Improved cardiac safety profile
Depression and other indications
New Chemical Entities
Safer Ibogaine Analogs
Rapid and sustained efficacy
Improved cardiac safety profile
Opioid abuse disorder and other indications
New Chemical Entity
